EUCTR2017-001765-25-Outside-EU/EEA进行中（未招募）1 期
An Investigation of the Safety and Efficacy of Elidel® 1% Cream in Atopic Disease Modification, Assessed in a 3-year Randomized Doubleblind Vehicle Controlled Phase to Evaluate Effects on Atopic Dermatitis in Infants, and a 2-3 Year Open-label Phase to Evaluate the Effect of Early Intervention Versus Delayed Intervention With Elidel® on the Incidence of Asthma in Children
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- ovartis
- 入组人数
- 1,091
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Diagnosis of atopic dermatitis
- •Family history of atopy
- •3 to 18 months of age at baseline
- •At least mild atopic dermatitis at baseline (investigator global
- •assessment [IGA] greater or equal to 2)
- •Clinical evidence of atopic dermatitis for no longer than 3 months
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range: 1091
- •F.1.2 Adults (18-64 years) no
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Diagnosis of or substantial clinical evidence for food or other allergies
- •at baseline
研究者
相似试验
尚未招募
2 期
Exploratory survey of the safety and efficacy of endoscopic radiofrequency ablation for malignant biliary strictureMalignant biliary strictureJPRN-UMIN000031601Graduate School of Medicine, Chiba University10
招募中
3 期
Investigating the effect of empagliflozin in heart failure in HIV patientsIRCT20130719014054N2Tehran University of Medical Sciences128
招募中
不适用
Evaluation of safety and effectiveness regarding intraocular cyclophotocoagulation for refractory glaucomaRefractory terminal glaucoma Glaucoma absolutumJPRN-UMIN000027090Sato Yuya Eye Clinic20
进行中（未招募）
不适用
A study of the efficacy, safety, and quality of life (QOL) in patients with chronic idiopathic urticaria dosed with AERIUS Tablets (5 mg, 10 mg, or 20 mg once daily). - ACCESubjects with an active episode of chronic idiopathic urticaria (CIU) and are taking a second-generation antihistamine will be selected for the study. The urticaria activity score (UAS) must be between 10-30, inclusive, at the end of the baseline week (entry period).MedDRA version: 8.1Level: LLTClassification code 10021247Term: Idiopathic urticariaEUCTR2006-001449-33-SESchering Plough Institute, A Division of Schering Corporation600
进行中（未招募）
不适用
A study of the efficacy, safety, and quality of life (QOL) in patients with chronic idiopathic urticaria dosed with AERIUS Tablets (5 mg, 10 mg, or 20 mg once daily). - ACCEEUCTR2006-001449-33-CZSchering-Plough Research Institute, A Division of Schering Corporation600